UBS Group AG - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$2,893,647
+22158.8%
193,555
+11567.0%
0.00%
Q3 2022$13,000
-7.1%
1,659
-23.2%
0.00%
Q2 2022$14,000
-54.8%
2,161
-60.4%
0.00%
Q1 2022$31,0000.0%5,454
-18.4%
0.00%
Q4 2021$31,000
+3000.0%
6,680
+3240.0%
0.00%
Q3 2021$1,0000.0%2000.0%0.00%
Q2 2021$1,000
-88.9%
200
-82.1%
0.00%
Q1 2021$9,000
-76.9%
1,116
-83.4%
0.00%
Q4 2020$39,000
+875.0%
6,705
+835.1%
0.00%
Q3 2020$4,000
-84.6%
717
-85.8%
0.00%
Q2 2020$26,000
+1200.0%
5,041
+886.5%
0.00%
Q1 2020$2,0005110.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$22,809,0000.60%
SECTORAL ASSET MANAGEMENT INC 1,151,175$6,642,0000.47%
X-Square Capital, LLC 75,952$438,0000.24%
SABBY MANAGEMENT, LLC 68,092$393,0000.08%
WealthTrust Axiom LLC 22,347$128,0000.05%
Opaleye Management Inc. 58,800$339,0000.04%
Trexquant Investment LP 64,838$374,0000.04%
PDT Partners, LLC 60,117$347,0000.02%
PERSONAL CFO SOLUTIONS, LLC 13,000$75,0000.02%
CVI Holdings, LLC 13,171$76,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders